Stock Evaluator: SeaStar Medical Holding Corporation (ICU)

SeaStar Medical Holding Corporation ICU

$3.03 -0.10 -3.19%
September 11, 2026 3:59:56 PM EST November 10, 2021 Volume: 44,973
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.

Commentary & Analysis


Financial Summary

Share Statistics ICU Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $13.4 $385.8 7%
Shares Out (Mil) 4.1 40.8 12%
Institutional Ownership 77.8% 83.6% 47%
Float (Mil) 4.4 34.7 11%
Beta -1.03 0.88 1%
Avg Daily Volume (000s) 46 291 28%
Price Change
(52-week)
(65.2%) 61.6% 11%
Growth ICU Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 11.8% na
Net Income (5yr) (29.9%) (5.8%) 14%
EPS (5yr) na 10.4% na
Dividends (5yr) na 0.0% 0%
Cash Flow (5yr) na (15.5%) na
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS na na na
Month Ago EPS na na na
# Rev Up na na na
# Rev Down na na na
Three Months Ago EPS na na na
Year/Year Chg na na na
Financials ICU Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $2 $119 3%
Net Income (TTM) (Mil) ($14) ($9) 27%
EPS (TTM) ($3.812) ($0.400) 9%
Operating Cash Flow (TTM) (Mil) ($14) ($3) 18%
Net Cash Flow (TTM) (Mil) na $1 na
Long-Term Debt (Q1) (Mil) $0 $23 0%
Enterprise Value (Q1) (Mil) $6 $371 6%
Valuation ICU Industry
Median
Percentile
(All Stocks)
P/B 3.00 2.74 65%
P/E na 25.1 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.5 na
Ratios ICU Industry
Median
Percentile
(All Stocks)
Gross Margin 92.6% 58.3% 94%
Net Margin (795.5%) (6.9%) 1%
ROA (160.0%) (12.7%) 3%
ROE (356.9%) (12.3%) 2%
Liabilities to Assets 50.3% 46.0% 42%
F-Score 3 4 18%

SeaStar Medical Holding Corporation did not pass any screens on 9/11/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors